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ABSTRACT
Lameness is one of the most significant endemic dis-
ease problems facing the dairy industry. Claw horn le-
sions (principally sole hemorrhage, sole ulcer, and white 
line disease) are some of the most prevalent conditions. 
Despite the fact that thousands of animals are treated 
for these conditions every year, experimental evidence 
is limited on the most effective treatment protocols. 
A randomized, positively controlled clinical trial was 
conducted to test the recovery of newly lame cows with 
claw horn lesions. Animals on 5 farms were locomotion 
scored every 2 wk. Cows were eligible for recruitment 
if they had 2 nonlame scores followed by a lame score 
and had a claw horn lesion on a single claw of a single 
foot. Following a therapeutic trim, enrolled cows were 
randomly allocated to 1 of 4 treatments: treatment 1—
no further treatment (positive control; TRM), treat-
ment 2—trim plus a block on the sound claw (TB), 
treatment 3—trim plus a 3-d course of the nonsteroidal 
anti-inflammatory drug (NSAID) ketoprofen (TN), 
treatment 4—trim plus a block plus ketoprofen (TBN). 
The primary outcome measure was locomotion score 35 
d after treatment, by an observer blind to treatment 
group. Descriptive statistics suggested that treatment 
groups were balanced at the time of enrollment, that is, 
randomization was successful. Based on a sound loco-
motion score (score 0) 35 d after treatment, the number 
of cures was 11 of 45 (24.4%) for TRM, 14 of 39 (35.9%) 
for TB, 12 of 42 (28.6%) for TN, and 23 of 41 (56.1%) 
for TBN. The difference between TBN and TRM was 
significant. To test for confounding imbalances between 
treatment groups, logistic regression models were built 
with 2 outcomes, either sound (score 0) or nonlame 
(score 0 or 1) 35 d after treatment. Compared with 
TRM, animals that received TBN were significantly 
more likely to cure to a sound outcome. Farm, treat-
ment season, lesion diagnosis, limb affected, treatment 
operator, and stage of lactation were included in the 
final models. Our work suggests that lameness cure is 
maximized with NSAID treatment in addition to the 
common practices of therapeutic trimming and eleva-
tion of the diseased claw using a block when cows are 
newly and predominantly mildly lame.
Key words:  dairy cow, lameness, claw horn lesion, 
randomized clinical trial
INTRODUCTION
Lameness in dairy cattle is a significant problem in 
intensive dairy industries around the world, causing 
production losses (Huxley, 2013) and discomfort, un-
dermining animal welfare (Whay et al., 1997). Achiev-
ing sustainable reductions in the levels of disease on 
farm requires a combination of 2 approaches: first, 
the implementation of effective farm-specific preven-
tion strategies to decrease the rate at which new cases 
develop, and second, early identification and prompt 
and effective treatment of clinical cases to reduce the 
duration of time over which animals are lame. Whereas 
the emphasis of the majority of recent research has 
rightly focused on identifying risk factors for lameness 
and disease prevention, the treatment of animals once 
they become lame must not be neglected.
Sole hemorrhage, sole ulcer, and white line disease 
(the most common claw horn lesions) are some of the 
most prevalent conditions causing lameness (Capion 
et al., 2008; Cramer et al., 2008). Despite the fact 
that many thousands of animals are routinely treated 
for these diseases, a recent systematic review of the 
peer-reviewed literature on the prevention and treat-
ment of foot lameness in cattle highlighted the deficit 
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of information in this area (Potterton et al., 2012). In 
literature published between 2000 and 2011, no papers 
were identified that were concerned with the treat-
ment of white line disease and only 3 were concerned 
with the treatment of sole ulcers. Of these, 2 were case 
studies (i.e., not experimental), and although the third 
was composed of primary research, it assessed dietary 
supplementation with biotin (Lischer et al., 2002) and 
is of limited use in the field. The authors concluded 
that virtually all the existing information on the treat-
ment of claw horn lesions appeared to be from anec-
dotal reports based on the experience and knowledge of 
experts working in the field. This does not mean to say 
that current treatment protocols are ineffective, rather 
it highlighted the deficit of experimental evidence on 
the most effective treatment, that is, those that lead to 
the highest cure rates in the shortest time.
An extension of the literature search described above 
confirms that very little primary research work has ever 
been published testing treatments for claw horn lesions; 
only 2 other peer-reviewed papers were identified. The 
first describes a randomized study conducted in Aus-
tralia that tested wooden blocks, rubberized shoes, 
and padded bandages containing copper sulfate for the 
treatment of a variety of claw horn lesions (Pyman, 
1997). Three and 7 d after treatment, a significantly 
high number of cows had recovered in the block and 
shoe groups compared with the bandage group; out-
come assessment was limited to 14 d after treatment 
by which time no differences between groups were 
apparent. In the second, dairy cows managed under 
New Zealand’s extensive pasture-based systems were 
randomly treated with a plastic shoe and the nonsteroi-
dal anti-inflammatory drug (NSAID) tolfenamic acid, 
following corrective trimming (Laven et al., 2008). The 
authors concluded treatments did not significantly dif-
fer in either nociceptive threshold or locomotion score 
over the 100-d outcome period. The objective of the 
present study was to compare 4 treatments for claw 
horn lesions in a randomized study under UK field 
conditions.
MATERIALS AND METHODS
Study Design and Reporting
A positively controlled, randomized clinical trial 
(RCT) with blind outcome observations was designed 
to test the recovery of dairy cows with claw horn lesions, 
treated using different protocols. The study hypothesis 
stated that the likelihood of claw-horn-lesion recovery 
depended on the treatment administered. Based on a 
binary primary outcome measure (lame or not lame) af-
ter treatment, a power calculation suggested that treat-
ment group sizes of 58 would detect a 25% difference in 
recovery rate between treatments (power value of 0.8, 
P ≤ 0.05). A difference of 25% was selected because 
it was considered clinically meaningful and likely to 
be large enough to warrant the additional cost of the 
treatments tested should they prove superior.
The study was positively controlled (i.e., no animals 
were left untreated) and conducted under the Veteri-
nary Surgeons Act 1966, which regulates acts of veteri-
nary surgery in the UK. The protocol was reviewed and 
approved by the University of Nottingham’s School of 
Veterinary Medicine and Science Ethical Review Com-
mittee before study instigation.
The study manuscript has been prepared in accor-
dance with the guidelines outlined in the REFLECT 
statement for reporting randomized controlled trials in 
livestock (O’Connor et al., 2010).
Herd Selection
A convenience sample of 5 commercial dairy farms 
was recruited in the East Midlands area of the UK, 
within close proximity to the University of Nottingham. 
To be eligible for enrollment, farms were required to 
have a herd lameness prevalence of above 20% at the 
start of the study and be undertaking routine measures 
to control digital dermatitis at the herd level (e.g., 
regular foot bathing). Farms were either known to the 
trial coordinators or were recruited through their vet-
erinary surgeons, who were asked to nominate clients 
they considered met the criteria and would be willing 
to participate. A short list of suggested farms were ap-
proached and visited to discuss the trial and to assess 
their lameness prevalence. Following an introductory 
phone call, one farm elected not to participate because 
they thought the trial would interfere with their day-to-
day farm management.
The 5 farms were between 187 and 353 (median 241) 
cows in size with 305-d adjusted milk yields ranging 
from 7,394 to 11,579 L (median = 10,381 L). Three 
of the farms (farms 2, 4, and 5) housed lactating 
cows continuously; the other 2 farms managed cows 
at pasture during the summer (~March–October) and 
in housing during winter. On all farms, lactating cows 
were accommodated in stalls with mats, mattresses, 
or waterbeds. Two farms (farms 2 and 4) milked cows 
in an automatic milking system; the remaining farms 
milked cows in conventional parlors, 2 times daily. All 
walkways and standing areas were concrete on all farms 
except farm 2, which had rubber matting throughout, 
and farm 3, which had rubber matting at the feed face 
of the high-yielding group. All farms undertook routine 
foot trimming, although scheduling ranged from as re-
quired to weekly sessions. Two farms (farms 1 and 2) 
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used an external professional foot trimmer, and on the 
other farms, trimming was conducted by farm staff. All 
the farm routines were that lame cows were treated as 
soon as they were identified or at weekly or fortnightly 
routine health sessions, depending on disease severity 
and staff availability. Farmers were advised to continue 
their normal procedures for identifying and treating 
lame cows throughout the study period.
Cow Selection and Enrollment Criteria
Beginning in December 2011, locomotion scoring of 
all cows in the lactating herd was undertaken at fort-
nightly intervals, by trained experienced observers (H. 
T., G. M. P., N. J. B. ), as cows exited the milking parlor 
(farms 1, 3, and 5) or in a passageway with a firm, level 
surface (farms 2 and 4). All animals in all herds were 
uniquely identified by freeze brand, which was used to 
distinguish individual cows. Dry cows and young stock 
were not scored. Cows were scored on a 6-point scale 
adapted from the Great Britain industry standard scor-
ing system (Table 1); for animals considered lame (>1), 
the lame limb was identified and recorded.
Animals were considered for enrollment if they pre-
sented with a new case of lameness in a single hind limb, 
that is, 2 successive nonlame scores (0 or 1) followed by 
a lame score (>1). Animals were excluded if they had 
received treatment for lameness in the same foot within 
120 d or treatment for lameness in another foot within 
90 d or had completed a course of parenteral antibiotics 
or NSAID within the previous 14 d.
Selected cows were examined within 48 h of the 
locomotion scoring. Animals were assessed for BCS ac-
cording to Edmonson et al. (1989) using a scale of 1 to 
5 with increments of 0.5. The lame foot was inspected 
with the animal restrained in a foot-trimming crush. 
Animals were excluded if they were diagnosed with 
interdigital necrobacillosis, active digital dermatitis (an 
M1, M2, or M4.1 lesion; Berry et al., 2012), substantial 
interdigital hyperplasia, or a significant hock lesion. 
Identification of the painful claw was attempted by 
lateral rotation of the claw resulting in a withdrawal 
reflex and the application of hoof testers. Each animal 
received a therapeutic trim of the whole foot (i.e., both 
claws) consisting of a standard trim, investigation and 
trimming out of any lesions identified, removal of dis-
eased and underrun horn, and rebalancing of the claw 
height to reduce weight bearing on the diseased claw 
(Toussaint Raven, 2002). Animals were excluded from 
the study when lesions were identified in both claws, 
that is, only animals with a claw horn lesion on one 
claw of a single lame hind leg were eligible for inclusion.
Animals that did not meet these enrollment criteria 
were treated but not enrolled. They took no further 
part in the study, but they could be considered again 
in the future provided the minimum lag periods since 
treatment had elapsed. Animals could only be enrolled 
in the study once; if they presented with lameness on 
the same or a different leg in the future, they were 
excluded.
Lesion Classification
Claw lesions identified during examination of the feet 
of enrolled animals were classified into 1 of 3 groups:
 1.  sole hemorrhage or sole ulceration (SHU): lesion 
or lesions composed of hemorrhage or an ulcer of 
the sole in any location;
 2.  white line disease (WLD): lesion or lesions of 
any severity (hemorrhage through to complete 
separation) at any location on the white line; 
and
Table 1. Locomotion scoring descriptors employed in a randomized clinical trial to test the recovery of dairy cows from claw horn lesions
Locomotion  
score1 Descriptor
0 Walks with even weight bearing and rhythm on all 4 feet, with a flat back. Long fluid strides possible.
1 Steps uneven (rhythm or weight bearing or strides shortened, affected limb or limbs not immediately identifiable).
2a Mild asymmetry in hind-limb movement. Decreased stride length on affected limb and slightly decreased stance duration 
with a corresponding increase in limb flight velocity on the nonaffected side. Walking velocity remains normal. Back may 
be raised.
2b Moderate asymmetry in hind-limb movement. Decreased stride length on affected limb and a distinct decrease in stance 
duration. Limb flight on the nonaffected limb is correspondingly faster and the overall walking velocity is reduced. Back 
usually raised.
3a Severe asymmetry in hind-limb movement. Marked decrease in stride length on affected limb and very short stance 
duration. Limb flight on nonaffected limb rapid and walking velocity reduced such that cow cannot keep up with healthy 
herd. Back raised.
3b Minimal or non-weight bearing on affected limb. Back raised. Reluctant to walk without encouragement.
1Adapted, with permission, from the DairyCo Mobility Score system, the Great Britain industry standard. Scores 2a and 2b and 3a and 3b can 
be amalgamated back to scores 2 and 3 in this system, respectively.
4480 THOMAS ET AL.
Journal of Dairy Science Vol. 98 No. 7, 2015
 3.  other claw horn lesion: any other claw horn le-
sion that could not be categorized as SHU or 
WLD or 2 or more different lesions on the same 
claw (e.g., SHU and WLD).
Randomization and Treatments Administered
Enrolled animals were randomly allocated to 1 of 4 
treatment groups (Table 2) using a computer-generated 
randomization plan (www.randomization.com, work 
conducted by H. T.) created in blocks of 4, with each 
of the 4 treatment groups included once in each block. 
Randomization was further blocked by farm and lesion 
type (SHU, WLD, or other), to ensure approximate 
temporal matching of equal numbers of cows with each 
diagnosis within each study farm. Group 1 (therapeutic 
trim only; TRM) was considered the positive control 
group. Following completion of the therapeutic trim, 
animals were allocated to treatment group by drawing 
from a card index box consecutively numbered cards 
that had the treatment written on the reverse side.
Drawing of the randomization cards and administra-
tion of treatments were conducted by trained veteri-
nary surgeons familiar with the treatment of lame cows 
and predominantly undertaken by a single operator (H. 
T.) with vacation cover (S. A., O. M., J. H., and J. 
R.). Operators administering treatments were not blind 
to the treatment administered. Enrolled animals were 
identified with a leg band on both hind limbs. Farmers 
were asked to continue managing them in accordance 
with normal farm management practices but were re-
quested not to treat them for lameness and to notify 
the researcher if they felt that further intervention was 
necessary. Farmers were not blind to treatment group; 
although they were not provided with a list of treat-
ments administered, the presence of therapeutic blocks 
could be observed and treatment with NSAID was re-
corded in their medicine records.
Treatment Follow-Up and Outcome Observations
Animals were reexamined 8 d (±3 d) after treat-
ment. If a foot block had been applied as part of the 
treatment protocol [treatment 2 (TB) and treatment 4 
(TBN)] and it was no longer present, it was reapplied. 
If locomotion score had deteriorated from that at the 
time of enrollment, animals were re-treated.
Animals in groups TB and TBN were reexamined 
for a second time, 28 d (±3 d) after treatment. If the 
block was still present, it was manually removed using 
trimming pincers and careful leverage. This was the 
only action undertaken at this time point, that is, no 
additional treatments were administered.
The primary outcome measure, locomotion score 35 
d (±4 d) after treatment, was conducted by an inde-
pendent observer (G. M. P.) blind to treatment group. 
That observer collected outcome scores with cows walk-
ing in isolation, on a firm, level surface. For animals 
considered lame (>1), the lame limb was identified and 
recorded. Following the blind outcome score, animals 
were body-condition scored using the method previ-
ously described, and the treated limb was elevated and 
examined for digital dermatitis and any other condi-
tions.
Additional Data Collected
Data on parity, monthly milk yield, and calving date 
were collated from farm records. Animals that were 
sold, culled, or died before assessment of the primary 
outcome measure were recorded and withdrawn from 
the study.
Data Collation and Statistical Analysis
Data collected for each cow at each visit were record-
ed onto data-capture forms and then transcribed and 
stored in a relational database (Access 2007, Microsoft 
Corporation, Redmond, WA). Data analysis was con-
ducted in Minitab 16 (Minitab Inc., State College, PA). 
Data were audited for validity and spurious records 
using entry rules set up in the database and by manu-
ally scanning for outlying data following sorting within 
each data category. For analysis, locomotion scores 2a 
and 2b and 3a and 3b were amalgamated to 2 and 3, 
respectively.
Differences between treatment groups at the time of 
enrollment were assessed by ANOVA (DIM and last 
recorded monthly yield) and using the Kruskal-Wallis 
test (lameness score at treatment, BCS at treatment 
and parity).
A successful treatment at study outcome (35 d after 
treatment) was defined as either (1) a sound locomo-
tion score (score 0) or (2) a nonlame score (score 0 or 
1). The proportions of successful treatments in animals 
that received TB, TN (treatment group 3), and TBN 
were each compared with TRM using the χ2 test. A 
Bonferroni corrected P-value was calculated to account 
for multiple comparisons; the significance probability 
was set at P ≤ 0.05 for a 2-tailed test.
To test for confounding effects in the results, a mul-
tivariable analysis was conducted. Logistic regression 
models were built in MLwiN (Version 2.1, Centre for 
Multilevel Modeling, University of Bristol, Bristol, UK), 
with the same outcomes described above: (1) a sound 
locomotion score (score 0) 35 d after treatment and (2) 
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a nonlame score (score 0 or 1) 35 d after treatment. 
Farm and treatment were forced into the models as 
categorical fixed effects. Other variables and plausible 
interactions were investigated by forward selection, for 
inclusion stepwise. Variables were eliminated from the 
model based on the Wald test if P ≤ 0.05. Variables 
tested included parity (1, 2, 3, ≥4), DIM, calving season 
(winter, spring, summer, autumn), season of treatment, 
locomotion score at treatment, lame leg at treatment, 
BCS at treatment and outcome, lesion classification 
(SHU, WLD, other), active digital dermatitis at out-
come (yes or no), re-treatment required at 8-d recheck 
visit (yes or no), reapplication of block required at 8-d 
recheck visit (yes or no), treatment operator [principal 
operator (H. T.) or other operators (S. A., O. M., J. H., 
J. R.)], and milk yield at the last 2 monthly recordings. 
Days in milk was tested as a linear mean centered vari-
able, a categorical variable in 30-d increments, and as 
a nonlinear variable, e(−0.065×DIM) (Silvestre et al., 2006).
To assess fit, model predictions were compared with 
the observed data in groups stratified by categori-
cal variables in the model, such as treatment group. 
Predictions were generated by simulation. The models 
were deemed adequate if observed values were within 
95% confidence intervals of prediction.
RESULTS
Study Inclusions
Between January 10, 2012, and January 31, 2013, 
a total of 512 cows met the initial selection criteria 
and were examined. Enrollment of cows on farm 3 was 
suspended on April 24, 2012, because of the very low 
numbers of animals that were becoming eligible for 
enrollment (i.e., the number of new cases of lameness 
had dropped substantially from the start of the study). 
Farm 5 was recruited as a replacement; enrollment 
began on July 17, 2012, and continued to the end of 
the study. Selection of cows on farm 3 recommenced 
on November 16, 2012, and continued to the end of 
the study. Of the selected and examined cows, 183 met 
all of the inclusion criteria and were enrolled into the 
RCT. The remaining 329 animals were not enrolled for 
the following reasons: 227 (68.9%) had a lesion on both 
claws; 27 (8.2%) had no visible lesion on either claw and 
no painful claw could be identified; 2 (0.6%) were no 
longer lame, 41 (12.5%) had active digital dermatitis, 
3 (0.9%) had interdigital necrobacillosis, 1 (0.3%) had 
an interdigital hyperplasia, 6 (1.8%) had a hock lesion, 
14 (4.3%) had been treated by farm staff, and 8 (2.4%) 
were not compliant with the study protocol.
The number of cows allocated to each of the treat-
ment groups by lesion diagnosis and farm is outlined 
in Table 3. In total 47 cows received TRM, 46 TB, 45 
TN, and 45 TBN. Of the enrolled cows, 171 (93.4%) 
presented with a locomotion score of 2 and 12 (6.6%) 
with a score of 3.
Study Exclusions
Sixteen enrolled cows were withdrawn before the pri-
mary outcome was assessed. One animal (farm 1, TN) 
was culled; 5 animals (farm 2, TB × 2; farm 4, TBN × 
1; farm 5, TB × 1 and TBN × 1) were withdrawn for 
noncompliance with the study protocol after enrollment 
(e.g., becoming unduly stressed or repeated collapsing 
in the crush); 4 animals (farm 2, TN × 1 and TBN × 1; 
farm 4, TB × 1 and TBN × 1) were re-treated by the 
farmer without informing the researcher, and 6 animals 
(farm 1, TB × 1 and TN × 1; farm 2, TB × 1; farm 4, 
TRM × 1 and TN × 1; farm 5, TRM × 1) were lost to 
the study or were unavailable for reassessment for other 
Table 2. Treatment administered in a randomized clinical trial designed to test the recovery of dairy cows from claw horn lesions
Treatment  
group Treatment Description
1 (TRM) Therapeutic trim only 
(positive control group)
1. Therapeutic trim applicable to the lesion
2 (TB) Therapeutic trim plus foot 
block
1. Therapeutic trim applicable to the lesion
2. Application of a foot block1 (Demotec 95, Demotec) to the unaffected claw
3 (TN) Therapeutic trim plus 
NSAID2
1. Therapeutic trim applicable to the lesion
2. Administration of a 3-d course of ketoprofen (Ketodale 100 mg/mL, Richter Pharma AG) 
administered by deep intramuscular injection at 3 mg of ketoprofen per kilogram of BW
4 (TBN) Therapeutic trim plus foot 
block plus NSAID
1. Therapeutic trim applicable to the lesion
2. Application of a foot block (Demotec 95) to the unaffected claw
3. Administration of a 3-d course of ketoprofen (Ketodale 100 mg/mL) administered by deep 
intramuscular injection at 3 mg of ketoprofen per kilogram of BW
1Approximately 110 mm long, 55 mm wide, and 23 mm deep. The block was positioned based on the experience of the worker in an attempt 
to replicate normal claw placement and weight distribution. Where necessary the block was positioned toward the heel (away from the toe) to 
ensure weight was borne on the flat of the block. Demotec, Nidderau Germany; Richter Pharma AG, Wels, Austria.
2NSAID = nonsteroidal anti-inflammatory drug.
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reasons (e.g., moved to a distant location or incorrectly 
identified). Of the remaining 167 enrolled animals, 6 
animals (farm 1, TRM × 1 and TB × 1; farm 2, TB × 
1 and TN × 1; farm 4, TB × 1 and TBN × 1) required 
re-treatment at the 8-d recheck visit. Two received ad-
ditional trimming, 2 had their foot block removed and 
repositioned, 1 was treated for digital dermatitis with 
topical oxytetracyline spray (Alamycin aerosol 3.58% 
wt/wt cutaneous spray solution, Norbrook, Newry, 
Northern Ireland), and 1 received treatment for a hock 
lesion by cleaning and the application of topical oxytet-
racyline spray. Seventeen animals that received TB (7 
animals) and TBN (10 animals) required the reapplica-
tion of a foot block at the 8-d recheck visit because it 
was no longer present. A total of 144 cows were treated 
by the principal operator (H. T.), and 23 cows were 
treated by other operators (S. A., J. R., J. H. or O. M.).
Descriptive Results and Univariate Analysis
The parity, DIM, last recorded milk yield, and BCS 
and lameness score at treatment of enrolled cows by 
treatment group are outlined in Table 4. Differences 
between groups were not significant.
The locomotion scores of enrolled cows at outcome, 
35 d after treatment, are outlined in Table 5. Based on 
a sound score (score 0), the number (and percentage) 
of successful treatments was 11 of 45 (24.4%) for TRM, 
14 of 39 (35.9%) for TB, 12 of 42 (28.6%) for TN, and 
23 of 41 (56.1%) for TBN. The difference between TBN 
and TRM was significant (Bonferroni corrected P = 
0.01).
Based on a nonlame score (score 0 or 1), the number 
(and proportion) of successful treatment was 31 of 45 
(68.8%) for TRM, 28 of 39 (71.8%) for TB, 32 of 42 
(76.2%) for TN, and 35 of 41 (85.3%) for TBN. The 
differences between groups were not significant.
Of the lame animals 35 d after treatment, the number 
(and proportion) of animals lame on the leg that was 
treated at enrollment was 8 of 14 (57.1%) for TRM, 4 
of 11 (36.4%) for TB, 5 of 10 (50%) for TN, and 5 of 6 
(83.3%) for TBN.
Logistic Regression Analysis
Of the enrolled cows, 85 and 66 had missing milk 
recording records in the preceding 1 and 2 mo, respec-
Table 3. Number of cows allocated to each of 4 treatment groups1 by lesion diagnosis and farm in a randomized clinical trial designed to test 
the recovery of dairy cows from claw horn lesions
Item
Lesion diagnosis
Total
Sole hemorrhage or ulcer White line disease Other lesion2
TRM TB TN TBN TRM TB TN TBN TRM TB TN TBN
Farm ID
 1 6 6 5 5 1 1 1 1 3 4 3 3 39
 2 4 5 5 5 4 4 3 4 3 2 3 3 45
 3 1 1 1 1 2 2 1 2 2 2 2 2 19
 4 8 7 8 8 2 2 2 1 4 4 4 4 54
 5 2 2 2 1 1 0 1 1 4 4 4 4 26
Total 21 21 21 20 10 9 8 9 16 16 16 16 183
Grand total 83 36 64  
1TRM = therapeutic trim only; TB = therapeutic trim plus block on the sound claw; TN = therapeutic trim plus 3-d course of nonsteroidal 
anti-inflammatory drug (NSAID); TBN = therapeutic trim plus block plus NSAID.
2Predominantly a combination of both sole hemorrhage or ulcer and white line disease.
Table 4. Descriptive statistics of animals in each of 4 treatment groups1 in a randomized clinical trial designed to test the recovery of dairy 
cows from claw horn lesions
Item TRM TB TN TBN
Parity2 [median (interquartile range)] 3 (2–4) 3 (2–4) 3 (2–3) 2.5 (2–3)
DIM2 [mean (SE)] 205 (126) 180 (111) 168 (100) 182 (102)
Last recorded milk yield2 [L, mean (SE)] 36.2 (10.8) 37.4 (10.8) 43.1 (9.1) 37.6 (9.4)
BCS at treatment2 [median (interquartile range)] 3 (2.5–3) 3 (2.5–3) 2.5 (2.5–3.375) 2.5 (2.5–3.5)
Lameness score at treatment2 [median (interquartile range)] 2 (2–2) 2 (2–2) 2 (2–2) 2 (2–2)
1TRM = therapeutic trim only; TB = therapeutic trim plus block on the sound claw; TN = therapeutic trim plus 3-d course of nonsteroidal 
anti-inflammatory drug (NSAID); TBN = therapeutic trim plus block plus NSAID.
2Differences between treatment groups were not significant.
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tively. Milk recording records in the 2 mo preceding 
treatment were tested in models based on subsets of 
the data set with no missing records. Eight animals had 
missing records for DIM and were discarded.
Model fit to the data was acceptable, and results of 
the logistic regression models are outlined in Table 6. 
In the first model testing cure to outcome (1) (score 
0), animals in the TBN group were significantly more 
likely to cure compared with cows in the TRM group 
(P ≤ 0.05). Cows treated on farm 5, compared with 
other study farms, and treatments in spring and au-
tumn, compared with treatments in winter, were less 
likely to cure.
In the second model testing cure to outcome (2) 
(score 0 or 1), treatment group was not significant; 
however, there was a trend for animals in the TBN 
group to be more likely to cure compared with cows in 
the TRM group (odds ratio = 3.2, 95% CI = 0.9–11.3). 
Table 5. Locomotion score 35 d after treatment in dairy cows recruited to a randomized clinical trial designed 
to test recovery from claw horn lesions
Treatment1
Locomotion score 35 d after treatment [score (%)]
02 12 2 3
TRM (n = 45) 11 (24.4) 20 (44.4) 14 (31.1) 0
TB (n = 39) 14 (35.9) 14 (35.9) 10 (25.6) 1 (2.6)
TN (n = 42) 12 (28.6) 20 (47.6) 10 (23.8) 0
TBN (n = 41) 23 (56.1) 12 (29.3) 6 (14.6) 0
1TRM = therapeutic trim only; TB = therapeutic trim plus block on the sound claw; TN = therapeutic trim 
plus 3-d course of nonsteroidal anti-inflammatory drug (NSAID); TBN = therapeutic trim plus block plus 
NSAID.
2Score 0 = sound; scores 0 and 1 = nonlame.
Table 6. Outcomes from logistic regression models in a randomized clinical trial designed to test the recovery 
of dairy cows from claw horn lesions (odds ratio scale unless shown otherwise)
Model term1
Outcome 1. Sound locomotion 
score  
(score 0) 35 d after treatment
Outcome 2. Nonlame locomotion 
score  
(score 0 or 1) 35 d after treatment
Odds ratio
95% CI
Odds ratio
95% CI
2.5% 97.5% 2.5% 97.5%
Intercept −1.08 −2.14 −0.05 3.28 0.82 13.1
TRM Reference   Reference   
TB 2.1 0.8 5.8 1.2 0.4 3.8
TN 1.2 0.4 3.2 1.3 0.4 4.3
TBN 6.4* 2.4 18.0 3.2 0.9 11.3
Farm 1 Reference   Reference   
Farm 2 0.6 0.2 1.8 0.7 0.2 2.5
Farm 3 1.3 0.4 4.3 3.6 0.6 21.9
Farm 4 1.2 0.5 3.5 1.1 0.3 4.0
Farm 5 0.1* 0.0 0.4 0.7 0.2 2.8
Right hind limb Reference   Reference   
Left hind limb 4.8* 2.3 10.5 2.3* 1.0 5.5
e−0.065×DIM (logit scale) 8.5* 3.5 13.9 7.8* 2.3 13.3
Winter treated Reference      
Spring treated 0.2* 0.1 0.4    
Summer treated 0.4 0.1 1.1    
Autumn treated 0.1* 0.0 0.3    
Sole ulcer or hemorrhage    Reference   
White line disease    0.8 0.2 2.6
Other lesion    0.3* 0.1 0.9
Principal treatment operator (H. 
T.)
   Reference 0.1 0.8
Other treatment operators 0.3*
1TRM = therapeutic trim only; TB = therapeutic trim plus block on the sound claw; TN = therapeutic trim 
plus 3-d course of nonsteroidal anti-inflammatory drug (NSAID); TBN = therapeutic trim plus block plus 
NSAID; spring = March, April, and May; summer = June, July, and August; autumn = September, October, 
and November; winter = December, January, and February.
*P ≤ 0.05.
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Cows with other lesions had lower odds of cure com-
pared with cows treated for SHU, and animals treated 
by other operators were less likely to cure than those 
treated by the principal operator.
In both models, animals treated on the left hind limb 
were more likely to cure (compared with those treated 
for lameness on the right hind limb), and cows were 
more likely to recover when treated in early lactation, 
with exponential decay in the relationship with time 
after calving.
DISCUSSION
In this study, lame cows treated for a claw horn lesion 
in a single claw of a single leg recovered at different 
rates depending on the treatment administered. Cows 
treated with a therapeutic trim, block, and NSAID 
were more likely to recover to a sound locomotion score 
than those treated with a therapeutic trim alone.
One of the surprising findings from our study was 
how small the differences in treatment success were be-
tween therapeutic trim and the application of a block 
to the sound claw and therapeutic trim alone. Only 
when an NSAID was added to the block and trim were 
significant differences in outcome seen. The applica-
tion of a block to the sound claw as a treatment for 
lameness is a common practice around the world. In 
a recent review of textbooks and gray literature (e.g., 
reports and control plans; Potterton et al., 2012), 85% 
of sources advocated their use for claw horn lesion. 
Behind a therapeutic trim, therapeutic blocks were the 
next most common treatment option described. Simi-
larly, in a recent survey of UK dairy farmers, more than 
90% reported using blocks and 70% considered trim 
and block an effective treatment for claw horn lesions 
(Horseman et al., 2013).
The etiology of claw horn lesions has not been fully 
elucidated; whatever the underlying cause, compres-
sion of the sole corium leads to vascular compromise, 
ischemia, hemorrhage, and ultimately interruption 
of keratogenesis and the development of lesions. The 
application of a block to the sound claw is thought 
to reduce load bearing and hence compression of the 
corium in the diseased claw and allow the compromised 
tissues to heal. It is noteworthy that only marginal, 
nonsignificant differences in cure rates were observed 
following the administration of NSAID without a block 
or a block without NSAID. This suggests that reduc-
tion in load bearing and NSAID action were synergistic 
in this study. We propose 2 hypotheses for this observa-
tion. First, the NSAID could be having a direct effect 
at the corium, reducing inflammation and assisting 
the corium to heal if loading is reduced by a block. 
Alternatively, it seems credible that blocks may cause 
some discomfort following application; this may modify 
behavior (e.g., changing lying or feeding time) or cause 
a redistribution of weight bearing between the claws 
and limbs, leading to a reduction in the rate of healing 
of the diseased claw. Administration of an NSAID in 
combination with a block may mitigate these possible 
changes. Our results provide some circumstantial evi-
dence of this effect. At outcome (35 d after treatment), 
6, 7, and 5 cows were lame on the contralateral hind 
leg in the TRM, TB, and TN groups, respectively; this 
compares to just 1 cow in the TBN group. Lame cows 
in the TRM, TB, and TN groups may have increased 
loading on the contralateral hind limb, predisposing it 
to lesion progression and lameness. Cows in the TBN 
group may have been comfortable to bear weight evenly 
on the lame limb, while at the same time the block 
allowed the diseased claw to heal. Further work is re-
quired to confirm our findings and better understand 
the mechanisms of action and benefits of different 
treatment options in cows with claw horn lesions.
Our results disagree with those reported by Laven 
et al. (2008), who saw no difference in outcomes be-
tween lame cows with claw horn lesions treated with 
blocks and the NSAID tolfenamic acid in addition to a 
therapeutic trim alone. Although the study designs are 
not directly comparable, they have a range of similari-
ties making comparisons between outcomes legitimate. 
The differences in outcome observed could be due to 
differences in case selection (identified by an external 
observer as soon as lame vs. identified by farm staff 
and therefore likely to be more chronically lame), man-
agement system (more intensive predominantly housed 
vs. more extensive predominantly pasture based), cow 
type (predominantly higher yielding Holstein type vs. 
predominantly lower yielding Friesian and Jersey type), 
or other unidentified factors.
The study population recruited to this RCT was 
a convenience sample. That said we have no reason 
to suspect that it was not broadly representative of 
both cow and farm types common in the UK (all be 
it that 2 of the study farms used automatic milking 
systems). Enrolled cows selected from this population 
were predominantly newly and mildly lame. A previous 
study reported a median lag of 65 d between when cows 
can first be identified as lame by an external observer 
and when they were identified for treatment by farmers 
(Leach et al., 2012). This may be because, as recent 
work suggests, many farmers do not identify or refer to 
milder cases as “lame” (i.e., score 2 in this study). It 
appears they reserve the term “lame” for more severe 
cases (i.e., score 3 in this study; Horseman et al., 2014). 
Consequently, if farmers do not consider that milder 
cases are “lame,” it stands to reason that they would 
not necessarily be considered for treatment. In our 
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study, animals were locomotion scored every 2 wk and 
treated as soon as they became identifiably lame. The 
period of time that could have elapsed between animals 
first becoming lame and being treated ranged between 
2 and 16 d (fortnightly locomotion scoring plus lag to 
treatment visit). The majority of cows (93%) presented 
with the mildest lameness classification (score 2). This 
population was selected first because we considered it 
ethically questionable to identify and then knowingly 
leave lame animals for several weeks before they were 
treated and second because we believe that these are 
the animals that the industry should be targeting for 
treatment. Readers should note that our study popula-
tion, and consequently our results, may not reflect the 
cases that many farmers routinely identify and present 
for treatment, and at this stage it is not possible to say 
whether our results are generalizable to more severe or 
chronic cases managed in different farm systems. Fur-
ther studies are needed to replicate this type of clinical 
trial to test treatment protocols in more chronically 
and severely lame animals, providing this work does 
not encourage or condone delayed treatment on farm.
A range of other variables were significant in the 
final models (i.e., they significantly affected cure), in-
cluding farm, limb treated, DIM, season of treatment, 
diagnosis, and operator. Of note, cure rates to sound-
ness on one farm (farm 5) were significantly worse than 
on other study farms. Despite identical case selection 
criteria, an unidentified factor or factors significantly 
affected outcome following all treatments on this unit. 
Clinically, it is important that farms with poor cure 
rates are identified and the reasons for poor responses 
are explored to limit the effects of this painful disease 
on health and welfare. It is also interesting to note that 
cows were more likely to recover from lameness when 
treated in early lactation and that the relationship ex-
ponentially decayed with time after calving. Although 
animals were not enrolled until at least 120 d had 
elapsed since their last treatment on the same limb, 
the reduction in treatment success could reflect lower 
recovery rates in feet with more chronic lesions from 
previous lameness events. Finally, the reasons for the 
difference in cure rates between left and right limbs is 
unclear; it could reflect an operator bias based on the 
relative ease of trimming left and right feet, depending 
on the dominant hand of the worker.
Logistically, this was a complex, expensive, and time-
consuming study protocol to conduct; this may explain 
why so few of these studies have been conducted previ-
ously. The low proportion of cows that met all the se-
lection criteria was particularly challenging; more than 
500 animals had to be examined and trimmed to enroll 
183 cows. The principal reason for exclusion, making 
up almost 70% of exclusion, was animals having le-
sions on both claws, that is, even if the claw causing 
the lameness was obvious, large numbers of animals 
had mild lesions on the contralateral claw. Although in 
practice, therapeutic blocks are often applied to claws 
with visible but mild lesions, we felt it important that 
this was not the case in a RCT. The use of blocks as 
part of treatment also necessitated an additional crush-
restraint intervention to remove blocks from treatment 
groups that had received them. We considered this nec-
essary first to blind treatment group from the outcome 
observer and second because work suggests that cows 
alter their gait while walking on blocks (Higginson Cut-
ler, 2012). Workers wishing to undertake studies such 
as this may wish to consider their selection criteria, 
case definitions, and study methodology carefully to 
avoid some of the logistical problems we encountered.
The study of lameness treatment protocols has lagged 
behind that of similarly important endemic diseases 
such as mastitis and infertility. In these fields clinical 
decision making is based on a plethora of research stud-
ies that have tested different treatments and identi-
fied the most effective protocols. It is incumbent on 
the industry and research community to find ways of 
ensuring that more studies such as this are conducted 
to provide a robust evidence base to support the effec-
tive treatments of this prevalent, costly, and painful 
endemic disease.
CONCLUSIONS
In the RCT described here, dairy cows with claw 
horn lesions treated with a therapeutic trim, a foot 
block on the sound claw, and a 3-d course of the NSAID 
ketoprofen were most likely to be sound 5 wk after 
treatment. Our work suggests that cows benefit from 
NSAID treatment in addition to the common practices 
of therapeutic trimming and elevation of the diseased 
claw using a foot block even when they are newly and 
mildly lame.
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